Inventor profile of:

Brad St. Croix

City:

Frederick, Maryland

Country:

United States

Published Applications:

25

Last publication date:

2023-02-02

Top Assignees for applications by Brad St. Croix

The entities that hold a legal rights for patent applications filed by inventor St. Croix Brad:

Recent patent applications by St. Croix Brad

Brad St. Croix from Frederick, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-02-02
US20230032465A1
Chemistry; metallurgy

ANTIBODY-DRUG CONJUGATES SPECIFIC FOR CD276 AND USES THEREOF

#2 | 2022-12-01
US20220380471A1
Chemistry; metallurgy

HIGH AFFINITY NANOBODIES TARGETING B7-H3 (CD276) FOR TREATING MULTIPLE SOLID TUMORS

#3 | 2017-12-14
US20170355765A1
Chemistry; metallurgy

TEM8 antibodies and their use in treatment and detection of tumors

#4 | 2017-05-04
US20170119883A1
Human necessities

Combination therapies using platinum agents and agents that target tumor-associated stroma or tumor cells

#5 | 2017-05-04
US20170119882A1
Human necessities

Combination therapies targeting tumor-associated stroma or tumor cells

#6 | 2017-05-04
US20170119881A1
Human necessities

Combination therapies targeting tumor-associated stroma or tumor cells and microtubules

#7 | 2017-04-27
US20170112928A1
Human necessities

Combination therapies targeting tumor-associated stroma or tumor cells and topoisomerase

#8 | 2017-04-27
US20170112927A1
Human necessities

Combination therapies using agents that target tumor-associated stroma or tumor cells and alkylating agents

#9 | 2017-04-27
US20170112926A1
Human necessities

Combination therapies using anti-metabolites and agents that target tumor-associated stroma or tumor cells

#10 | 2017-04-13
US20170101464A1
Chemistry; metallurgy

Combination therapies using agents that target tumor-associated stroma or tumor cells and tumor vasculature

#11 | 2017-04-06
US20170095575A1
Human necessities

Combination therapies using agents that target tumor-associated stroma or tumor cells and other pathways

#12 | 2016-11-03
US20160319016A1
Chemistry; metallurgy

Antibodies to tumor endothelial marker 8

#13 | 2016-09-15
US20160264662A1
Chemistry; metallurgy

TEM8 antibodies and their use in treatment and detection of tumors

#14 | 2016-07-07
US20160194720A1
Chemistry; metallurgy

DIFFERENTIAL GENE EXPRESSION IN PHYSIOLOGICAL AND PATHOLOGICAL ANGIOGENESIS

#15 | 2014-05-15
US20140134179A1
Chemistry; metallurgy

TEM8 antibodies, conjugates thereof, and their use

#16 | 2013-12-05
US20130323173A1
Chemistry; metallurgy

Antibodies to tumor endothelial marker 8

#17 | 2013-08-08
US20130202528A1
Chemistry; metallurgy

DIFFERENTIAL GENE EXPRESSION IN PHYSIOLOGICAL AND PATHOLOGICAL ANGIOGENESIS

#18 | 2011-08-25
US20110207141A1
Chemistry; metallurgy

Differential gene expression in physiological and pathological angiogenesis

#19 | 2011-05-05
US20110104059A1
Chemistry; metallurgy

Membrane Associated Tumor Endothelium Markers

#20 | 2010-02-04
US20100028256A1
Chemistry; metallurgy

DIFFERENTIAL GENE EXPRESSION IN PHYSIOLOGICAL AND PATHOLOGICAL ANGIOGENESIS

#21 | 2009-09-17
US20090233270A9
Physics

Secreted and cytoplasmic tumor endothelial markers

#22 | 2008-07-01
US10474794
-

Endothelial cell expression patterns

#23 | 2006-12-07
US20060275287A1
Chemistry; metallurgy

Scroll compressor

#24 | 2006-09-21
US20060210975A1
Physics

Secreted and cytoplasmic tumor endothelial markers

#25 | 2005-06-30
US20050142138A1
Chemistry; metallurgy

Endothelial cell expression patterns

InventorID:

376163 ⎘